Core Viewpoint - The company, 加科思药业, has demonstrated strong confidence in its fundamentals and long-term growth prospects through significant share buybacks and insider purchases by its CEO and associates [1] Group 1: Stock Performance - 加科思-B (01167) shares rose over 3%, specifically by 3.28%, reaching HKD 9.45, with a trading volume of HKD 30.1853 million [1] Group 2: Insider Transactions - The company's chairman and CEO, Dr. Wang Yinxiang, along with associates, invested nearly HKD 100 million to purchase over 11.05 million shares [1] Group 3: Share Buyback Program - The previously announced HKD 100 million share buyback program has commenced, with approximately HKD 26.7 million executed so far, and it is expected to continue over the next year [1] Group 4: Business Operations and Product Pipeline - The company reported that its business operations are currently in good condition, with encouraging progress in the development of its core product pipeline, including the Pan-KRAS inhibitors [1]

Core Viewpoint - The company demonstrates strong confidence in its future development prospects, as evidenced by significant share purchases by concerted action members and a share buyback plan [1][2] Group 1: Share Purchases - Concerted action members have collectively purchased 11.05865 million shares at a total cost of approximately 96.34 million HKD since July 16, 2025 [1] - As of the announcement date, these members hold about 200.2 million shares, representing 25.28% of the company's total issued shares [1] - The members express confidence in the company's overall development prospects, growth potential, and long-term investment value [1] Group 2: Share Buyback Plan - The board has approved a share buyback plan not exceeding 100 million HKD, believing that the current share price does not reflect the company's actual value [1] - Since July 15, 2025, the company has repurchased a total of 326,400 shares, with a cumulative payment of 2.67 million HKD [1] - The company will continue to monitor market conditions and may exercise shareholder authorization for further share repurchases [1] Group 3: Business Operations and Product Pipeline - The board believes that the company's current business operations are in good condition, with encouraging progress in the development of core product pipelines, including but not limited to Pan-KRAS inhibitors [2] - The management's substantial share purchases and the company's share buyback actions reflect a strong confidence in the company's fundamentals and long-term growth prospects [2]

Core Viewpoint - The company, 加科思-B (01167), has received notification from its concerted action members expressing strong confidence in the company's future development prospects, leading to significant share purchases and a share buyback program [1] Group 1: Share Purchases - From July 16, 2025, to the date of the announcement, concerted action members have collectively purchased 11,058,650 shares at a total cost of approximately HKD 96.34 million [1] - As of the announcement date, these members hold a total of 200 million shares, representing about 25.28% of the company's total issued shares [1] Group 2: Share Buyback - Since July 15, 2025, the company has repurchased a total of 326,400 shares, with a cumulative payment of HKD 2.67 million [1] - The company plans to continue monitoring market conditions and may exercise shareholder authorization for further share repurchases based on market circumstances [1] Group 3: Business Outlook - The company reports that its current business operations are performing well, with encouraging progress in the research and development of its core product pipeline, including the Pan-KRAS inhibitor [1] - The management's substantial share purchases and the company's share buyback actions reflect a strong confidence in the company's fundamentals and long-term growth prospects [1]

Core Viewpoint - Tianli International Holdings (01773.HK) announced that its Executive Director, Chairman, and CEO, Mr. Luo Shi, purchased 2 million shares of the company at an average price of approximately HKD 3.83 per share, representing about 0.09% of the total issued shares [1] Group 1 - Following the purchase, Mr. Luo holds a total of 907,455,569 shares, accounting for approximately 43.02% of the company's total issued shares as of the announcement date [1] - Mr. Luo expressed confidence in the business outlook and does not rule out the possibility of further increasing his shareholding at an appropriate time, subject to applicable laws and regulations [1] Group 2 - On the same date, the company repurchased 1.59 million shares, which is about 0.08% of the total issued shares [1] - The board believes that the share repurchase under current market conditions demonstrates confidence in the company's business outlook and will ultimately benefit the company and create value for shareholders [1] - The company may consider further share repurchases in accordance with all applicable laws and regulations at an appropriate time [1]

Group 1 - Xin Feng Ming's controlling shareholder plans to increase its stake in the company with an investment of between 200 million to 300 million yuan within one year [1] - The increase in shareholding reflects confidence in the company's future development and is expected to have a positive impact on the stock price [1] - However, there are risks associated with market fluctuations that may prevent the plan from achieving its intended results [1] Group 2 - Zijin Mining has completed its share repurchase plan, spending approximately 1 billion yuan to buy back 64.316 million shares, which is 0.24% of its total share capital [2] - The repurchase was conducted at an average price of 15.55 yuan per share, slightly below the current market price, which may provide some support for the stock price [2] - Zijin Mining has announced a new repurchase plan with a budget of 600 million to 1 billion yuan [2] Group 3 - Satellite Chemical plans to repurchase shares with a budget of between 200 million to 400 million yuan to implement employee stock ownership plans or other equity incentive plans [3] - This repurchase plan indicates the company's focus on employee incentives and recognition of its own value [3] - The impact of the repurchase on the stock price is anticipated to be positive, but the actual effect will depend on market reactions and the company's future performance [3]

Group 1 - The core viewpoint of the announcements is that the management of Hars (002615) demonstrates confidence in the company's future development and long-term value through share buyback and shareholding increase plans [1][2] Group 2 - On April 8, Hars announced that its controlling shareholder's concerted actors plan to increase their shareholding by an amount not less than 6 million yuan and not exceeding 12 million yuan within six months [1] - The increase in shareholding is based on the confidence in the company's sustainable development and long-term investment value, aiming to enhance investor confidence and protect the interests of investors [1] - The increase plan does not set a fixed price range, indicating the flexibility of the shareholders in responding to market conditions and their firm belief in the company's value [1] Group 3 - On April 9, the chairman of Hars proposed a share buyback plan, with a total amount not less than 80 million yuan and not exceeding 160 million yuan, to be funded by the company's own or self-raised funds [2] - The buyback shares will be used for future equity incentive plans or employee stock ownership plans, with any unused shares to be canceled if not utilized within 36 months [2] - The chairman has committed to supporting the buyback plan and has not engaged in buying or selling company shares in the past six months, reflecting a strong commitment to the plan [2] Group 4 - For the first three quarters of 2024, Hars achieved operating revenue of 2.367 billion yuan, a year-on-year increase of 38.77%, and a net profit of 225 million yuan, a year-on-year increase of 47.03% [3] - According to Haitong Securities research, Hars' multi-brand strategy covers different customer groups, and with increased investment in its own brands, steady growth is expected for these brands [3]